| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、经营活动产生的现金流量: | | | | |
| 销售商品、提供劳务收到的现金 | 7,858,447.28 | 3,925,973.64 | 11,814,993.84 | 11,940,493.84 |
| 收到其他与经营活动有关的现金 | 208,008.67 | 116,340.96 | 5,534,369.13 | 4,239,534.41 |
| 经营活动现金流入小计 | 8,066,455.95 | 4,042,314.6 | 17,349,362.97 | 16,180,028.25 |
| 购买商品、接受劳务支付的现金 | - | - | 3,047.99 | - |
| 支付给职工以及为职工支付的现金 | 876,039.11 | 520,667.68 | 1,450,333.88 | 1,113,237.82 |
| 支付的各项税费 | 2,879,573.28 | 1,340,125.2 | 7,916,096.14 | 6,803,491.77 |
| 支付其他与经营活动有关的现金 | 1,936,204.78 | 368,148.54 | 2,090,736.18 | 1,788,274.3 |
| 经营活动现金流出小计 | 5,691,817.17 | 2,228,941.42 | 11,460,214.19 | 9,705,003.89 |
| 经营活动产生的现金流量净额 | 2,374,638.78 | 1,813,373.18 | 5,889,148.78 | 6,475,024.36 |
| 二、投资活动产生的现金流量: | | | | |
| 收回投资收到的现金 | 60,210,000 | 20,210,000 | 150,000,000 | 110,000,000 |
| 取得投资收益收到的现金 | 172,355.85 | 53,200.77 | 332,847.79 | 175,600.4 |
| 处置子公司及其他营业单位收到的现金净额 | 51,300,000 | - | - | - |
| 投资活动现金流入小计 | 111,682,355.85 | 20,263,200.77 | 150,332,847.79 | 110,175,600.4 |
| 购建固定资产、无形资产和其他长期资产支付的现金 | 1,796 | 1,796 | 8,943.38 | 3,954 |
| 投资支付的现金 | 120,210,000 | 40,210,000 | 90,000,000 | 70,000,000 |
| 投资活动现金流出小计 | 120,211,796 | 40,211,796 | 90,008,943.38 | 70,003,954 |
| 投资活动产生的现金流量净额 | -8,529,440.15 | -19,948,595.23 | 60,323,904.41 | 40,171,646.4 |
| 三、筹资活动产生的现金流量: | | | | |
| 支付其他与筹资活动有关的现金 | 2,052,381.44 | 26,499 | 16,607,419.38 | 16,554,421.38 |
| 筹资活动现金流出小计 | 2,052,381.44 | 26,499 | 16,607,419.38 | 16,554,421.38 |
| 筹资活动产生的现金流量净额 | -2,052,381.44 | -26,499 | -16,607,419.38 | -16,554,421.38 |
| 四、汇率变动对现金及现金等价物的影响 | -13,073.15 | -2,974.76 | -357,945.39 | -459,042.39 |
| 五、现金及现金等价物净增加额 | -8,220,255.96 | -18,164,695.81 | 49,247,688.42 | 29,633,206.99 |
| 加:期初现金及现金等价物余额 | 65,934,102.24 | 65,934,102.24 | 16,686,413.82 | 16,686,413.82 |
| 期末现金及现金等价物余额 | 57,713,846.28 | 47,769,406.43 | 65,934,102.24 | 46,319,620.81 |
| 补充资料: | | | | |
| 净利润 | 42,191,778.95 | - | 8,091,520.38 | - |
| 固定资产和投资性房地产折旧 | 553,135.38 | - | 1,213,089.28 | - |
| 其中:固定资产折旧、油气资产折耗、生产性生物资产折旧 | 553,135.38 | - | 1,213,089.28 | - |
| 公允价值变动损失 | -2,165.25 | - | 13,986.98 | - |
| 财务费用 | - | - | 384,053.4 | - |
| 投资损失 | -51,352,844.29 | - | 1,561,408.22 | - |
| 经营性应收项目的减少 | 1,852,899.57 | - | -4,220,235.96 | - |
| 经营性应付项目的增加 | 9,952,679.4 | - | -2,557,455.5 | - |
| 其他 | -870,625 | - | 1,176,138.88 | - |
| 现金的期末余额 | 57,713,846.28 | - | 65,934,102.24 | - |
| 减:现金的期初余额 | 65,934,102.24 | - | 16,686,413.82 | - |
| 现金及现金等价物的净增加额 | -8,220,255.96 | - | 49,247,688.42 | - |
| 公告日期 | 2025-08-09 | 2025-04-19 | 2025-03-29 | 2024-10-26 |
| 审计意见(境内) | | | 标准无保留意见 | |